Superstar Platforms (SPST) Research & Development (2025)
Superstar Platforms' (SPST) quarterly Research & Development came in at $3533.0 in Q2 2025, up 739.19% quarter-over-quarter from $421.0 in Q1 2025.
Powered by 
Analysis
Superstar Platforms (SPST) Research & Development (2025) Analysis & Trends
Superstar Platforms (SPST) has reported Research & Development for 1 consecutive years, with $3533.0 the latest figure, recorded in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | 97.90 Mn |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | - |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | -1.97 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | -249.97 Mn |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | - |
| 10 | Superstar Platforms | 3.65 Mn | 3.65 Mn | - | - |